+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Increased replication of respiratory syncytial virus in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys pre-immunized with a formalin-inactivated RSV vaccine



Increased replication of respiratory syncytial virus in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys pre-immunized with a formalin-inactivated RSV vaccine



Journal of General Virology 82(11): 2663-2674



The pathology of respiratory syncytial virus (RSV) disease in bonnet monkeys parallels findings with human RSV disease. RSV-infected animals pre-immunized with a formalin-inactivated (FI) RSV vaccine develop inflammation in peribronchiolar, perivascular, interstitial and intra-alveolar sites with lung inflammation scores significantly higher than animals with a primary RSV infection and those pre-immunized with an FI-Vero cell control vaccine (P=0.05). Animals previously infected and re-exposed to RSV had significantly lower alveolar, interstitial and total lung inflammation scores than in primary infection (P=0.05). Immunization with two intra-muscular doses of 0.5 ml of the FI-RSV vaccine administered 21 days apart resulted in little serum-neutralizing and ELISA antibody, low levels of secretory IgA and a low lymphocyte proliferative response that was significantly lower than the response observed in animals that were previously infected with live RSV. Higher RSV virus titres were detected in the lungs and lung lavage fluid of monkeys immunized with the FI-RSV vaccine than in those with a primary infection (P=0.001). RSV was detected by in situ hybridization in pulmonary inflammatory infiltrates, where the single most abundant infiltrating cellular species was macrophages, so it may be these cells that support the enhanced virus replication that contributes to the enhanced pulmonary pathology of FI-RSV immunization.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035119945

Download citation: RISBibTeXText


Related references

Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. Journal of General Virology 82(Pt 11): 2663-2674, 2001

Enhanced pulmonary histopathology induced by respiratory syncytial virus challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 and IL-10. Journal of Virology 68(8): 5321-5325, 1994

Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV. Journal of Virology 71(9): 6935-6939, 1997

Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. Journal of Virology 70(5): 2852-2860, 1996

A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. Journal of Infectious Diseases 167(3): 553-561, 1993

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin inactivated respiratory syncytial virus rsv or purified f glycoprotein and challenged with rsv 3 6 months after immunization. Vaccine 8(5): 497-502, 1990

Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate. Vaccine 21(19-20): 2651-2660, 2 June, 2003

Immune responses to respiratory syncytial virus G glycoprotein are not necessary for formalin-inactivated RSV vaccine-enhanced disease. FASEB Journal 17(7): C24, 2003

Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV. Journal of Virology 78(11): 6024-6032, 2004

Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon. Vaccine. 11(14): 1415-1423, 1993

Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine 25(27): 5034-5040, 2007

Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease. Antiviral Research 104: 1-6, 2014

Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV. Journal of Virology 78(16): 8753-8760, 2004

Vb14+ T Cells Mediate the Vaccine-Enhanced Disease Induced by Immunization with Respiratory Syncytial Virus (RSV) G Glycoprotein but Not with Formalin-Inactivated RSV. Journal of Virology 78(16): 53-60, 2004

Detection of respiratory syncytial virus rsv infected cells by in situ hybridization in the lungs of cotton rats immunized with formalin inactivated virus or purified rsv f and g glycoprotein subunit vaccine and challenged with rsv. Virus Research 16(2): 153-162, 1990